Important pharmacy news and late-breaking industry information updated daily.
FDA Commissioner Scott Gottlieb said the "easy availability of opioids online" has become "a major public health concern," as federal regulators increased pressure on major internet firms to do more to prevent such sales. Internet industry leaders met with government officials at a summit meeting Wednesday.
Rite Aid has issued a letter to its shareholders highlighting the merits of its proposed merger with Albertsons, in an effort to gain shareholder approval for the $24 billion deal at an August 9 special shareholder meeting. The letter cites the merger's potential to grow the company’s scale and diversity its business.
Cannabidiol drug approved for use in two forms of epilepsy
Theresa Tolle emphasized pharmacists’ role in containing costs for patients
FDA approved on Monday cannabidiol (Epidiolex—GW Research Ltd.) oral solution for the treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome—two rare and severe forms of epilepsy—in patients aged 2 years and older.
Research may nudge asthma guideline update
Pharmacists can discuss with suppliers and map projections to patient needs
New York state officials have said the cystic fibrosis drug ivacaftor–lumacaftor (Orkambi—Vertex Pharmaceuticals), which costs $272,000 a year but has been shown to only modestly help patients, is not worth its price, and are demanding that Vertex give a steeper discount to the state's Medicaid program.
The Trump administration has proposed transferring most of the responsibility for regulating food safety from FDA to the Department of Agriculture (USDA), and to rename FDA the "Federal Drug Administration." The proposal is part of a plan released Thursday that includes other broader ideas to reform HHS, including renaming it the "Department of Hea
There is growing support to allow pharmacists to prescribe medications, according to a <I>British Journal of Clinical Pharmacology</I> review of a large number of studies in many countries.